I try not to predict SP, but focus more on underlying value... 'Sentiment' affects different companies in different ways.
SP and value are not necessarily the same thing as sentiment...we achieved a SP of 21 cents (Jan 2021) with only
a sniff of proposed trials, therefore, successful trials would leave that previous SP level in its wake, one would think!
Let's see what transpires...for now, we don't have the data or any technical detail re the progress of the current trial
to predict more detailed and accurate modelling. I'm confident that the trial will prove successful (I may be wrong) but
the signs are there, i.e. the recent expansion of premisses for the proposed expansion of the manuf/development of
our tech, and the recent recruitment of multiple specialised personnel to join the IBX team all indicate confidence by
the Co that things are progressing in a positive manner.
Of course, more welcome would be clarity on the much-discussed and now seemingly overdue news on trial progress.
Cannot be too much longer!
- Forums
- ASX - By Stock
- IBX
- 20c.mark
IBX
imagion biosystems limited
Add to My Watchlist
8.33%
!
1.1¢

20c.mark, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $2.214M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $1.796K | 158.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1508101 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 85335 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1508101 | 0.011 |
13 | 2335039 | 0.010 |
6 | 933318 | 0.009 |
5 | 850749 | 0.008 |
2 | 628570 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 85335 | 1 |
0.013 | 2895531 | 2 |
0.014 | 209999 | 1 |
0.015 | 567754 | 3 |
0.016 | 275757 | 3 |
Last trade - 14.49pm 04/07/2025 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online